PMA P230011S007

Device
TruSight Oncology Comprehensive
Applicant
Illumina, Inc.
PMA number
P230011
Supplement
S007
Product code
PQP
Decision date
2026-04-23
Classification
Pathology
Generic name
Next generation sequencing oncology panel, somatic or germline variant detection system
Approval order statement
Labeling changes updating troubleshooting instructions.

Current openFDA PMA Record#

Device
TruSight Oncology Comprehensive
Applicant
Illumina, Inc.
PMA number
P230011
Supplement
S007
Product code
PQP
Generic name
Next generation sequencing oncology panel, somatic or germline variant detection system
Decision date
2026-04-23
Decision code
APPR
Date received
2026-03-27
Supplement type
Real-Time Process
Supplement reason
Labeling Change - Indications/instructions/shelf life/tradename
Approval order statement
Labeling changes updating troubleshooting instructions.